Wednesday August 15, 2018

Researchers Identified Protein Associated With Breast Cancer

In HER2-positive breast cancers, cells with high levels of AXL are more likely to detach from tumours to form metastases.

0
//
34
High vitamin D harming Breast Cancer, Pixabay
Republish
Reprint

Researchers have found that a protein that, once deactivated, could prevent the spread of an aggressive type of breast cancer to other sites in the body, a process known as metastasis.

In their study, published in the journal Cell Reports, the researchers demonstrated that a protein, AXL, influences the occurrence of metastasis in HER2-positive cancer, an aggressive type that accounts for 20 per cent of breast cancers.

In HER2-positive breast cancers, cells with high levels of AXL are more likely to detach from tumours to form metastases.

Researchers have found that a protein that, once deactivated, could prevent the spread of an aggressive type of breast cancer to other sites in the body, a process known as metastasis.
Representational Image, pixabay

The research was done on mice and with samples of tumour cells taken from cancer patients in Montreal, Canada.

In women with HER2-positive cancer, it was found that the less AXL is present, the better the survival rate.

Also Read: To Fight Air Pollution, Delhi Scientists Are Turning Smoke Into Ink

Previously, researchers had linked the AXL protein to another type of cancer, triple negative breast cancer, but its role in in HER2-positive cancer was not known.

“Based on this discovery, a treatment targeting AXL could reduce the risk of metastasis,” said one of the researchers Jean-Francois Cote, Professor at Universite de Montreal in Canada. (IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Researchers Unveil the Power of Turmeric in Fighting Cancer

Curcumin is also known to exhibit anti-cancer properties, but its poor solubility in water had impeded curcumin's clinical application in cancer

0
Cancer
Indian-American researchers unleash turmeric's power to fight cancer. Pixabay

A team of Indian-American researchers at the University of Illinois at Urbana-Champaign (UIUC) and at the University of Utah at Salt Lake City, has used an ingenious process to enable curcumin to kill cancer cells.

Curcumin is the active ingredient of turmeric (haldi), the ubiquitous kitchen spice that gives curry its yellow color. Turmeric has been used in India for thousands of years as a spice and medicinal herb because of its powerful anti-inflammatory and strong antioxidant property.

Curcumin is also known to exhibit anti-cancer properties, but its poor solubility in water had impeded curcumin’s clinical application in cancer. A drug needs to be soluble in water as otherwise it will not flow through the bloodstream.

Despite decades of research, the development of efficient strategies that can effectively deliver poorly water-soluble curcumin to cancer cells had remained a challenge.

A team headed by Dipanjan Pan, associate professor of bioengineering at UIUC, has now found a way out.

“Curcumin’s medicinal benefit can be fully appreciated if its solubility issue is resolved,” Pan told this correspondent in an e-mail.

turmeric
Indian-American researchers unleash turmeric’s power to fight cancer. Pixabay

Pan’s laboratory collaborated with Peter Stang at the University of Utah on ways to be able to render curcumin soluble, deliver it to infected tumors and kill the cancer cells.

Because platinum is a commonly used cancer therapeutic agent in the clinic, the researchers decided to experiment with a drug consisting of a combination of platinum and curcumin.

“It is a combination of clever chemistry and nano-precipitation utilising host guest chemistry,” Pan explained. “The sophisticated chemistry leads to self-assembled hierarchical structure that drives the solubility of curcumin and simultaneously delivers an additional anticancer agent, i.e. platinum. The combined therapeutic effect — of curcumin and platinum — is lethal for the cancer cells.”

The team has reported its work in the “Proceedings of the National Academy of Sciences” in the US.

According to their report, the metallocyclic complex created using platinum “not only enabled curcumin’s solubility, but proved to be 100 times more effective in treating various cancer types such as melanoma and breast cancer cells than using curcumin and platinum agents separately”.

You May Also Wish to Read- 6 mn Indians Can be Helped With Advanced Low-Vision Aid

“Our results demonstrate that curcumin works completely in sync with platinum and exerts synergistic effect to show remarkable anticancer properties,” says the report. “The platinum-curcumin combination kills the cells by fragmenting its DNA.”

“Extensive animal studies are in progress in my laboratory, including in rodents and pigs,” Pan said. His team also hopes to prove that this method will be effective in killing cancer stem cells — the birth place of cancer cells — thereby preventing the recurrence of cancer.

Pan’s team included post-doctoral researcher Santosh Misra at UIUC, and Sougata Datta, Manik Lal Saha, Nabajit Lahiri, Janis Louie, and Peter J. Stang from the University of Utah. (IANS)